- Home
- VNT vs TFX Comparison
VNT vs TFX Comparison
Compare VNT & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VNT | TFX |
|---|---|---|
| Founded | 2019 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.6B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | VNT | TFX |
|---|---|---|
| Price | $36.31 | $107.90 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 9 |
| Target Price | $47.56 | ★ $140.25 |
| AVG Volume (30 Days) | ★ 1.2M | 873.2K |
| Earning Date | 05-14-2026 | 05-27-2026 |
| Dividend Yield | 0.26% | ★ 1.22% |
| EPS Growth | ★ 0.36 | N/A |
| EPS | ★ 2.76 | N/A |
| Revenue | ★ $3,075,600,000.00 | $1,992,713,000.00 |
| Revenue This Year | $2.65 | $46.78 |
| Revenue Next Year | $4.31 | $3.86 |
| P/E Ratio | $13.69 | ★ N/A |
| Revenue Growth | ★ 3.24 | N/A |
| 52 Week Low | $27.22 | $100.18 |
| 52 Week High | $48.20 | $143.32 |
Technical Indicators
Market Signals| Indicator | VNT | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 31.02 | 40.94 |
| Support Level | $34.65 | $102.03 |
| Resistance Level | $37.11 | $108.01 |
| Average True Range (ATR) | 1.07 | 4.37 |
| MACD | -0.56 | -0.95 |
| Stochastic Oscillator | 0.00 | 0.93 |
Price Performance
Historical ComparisonAbout VNT Vontier Corporation
Vontier, spun off from Fortive in 2020, is an industrial technology company with a portfolio of transportation and mobility solutions. The company offers a wide array of products and services, including fueling equipment, sensors, point-of-sale and payment systems, telematics, and equipment used by vehicle mechanics and technicians. Vontier generated approximately $3.1 billion in sales in 2025.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.